Community Advisory Board

Readers Rep

Markets:

Overview

News

Currencies

International

Treasuries

Vanguard Extended Market ETF (NY:VXF)

242.12 +2.56 (+1.07%)

Streaming Delayed Price Updated: 12:35 PM EDT, Sep 3, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Vanguard Extended Market ETF

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

SpaceX Is Up 25% in August. Meet the 7 Vanguard ETFs That Just Bought More Shares. ↗

August 20, 2026

Exchange-traded funds could be ramping up their SpaceX holdings as shares are unlocked and the stock price recovers.

Via The Motley Fool

Topics ETFs

How Is SpaceX (SPCX) Already the Largest of 3,372 Holdings in This $97.7 Billion Vanguard ETF? ↗

July 25, 2026

SpaceX's small float is leading to some rather unusual buying behavior from top ETFs.

Via The Motley Fool

Topics ETFs

Meet the 9 Vanguard ETFs That Are Buying SpaceX Stock in Droves. Here's My Top Pick of the Bunch. ↗

July 24, 2026

Nine Vanguard ETFs collectively bought $6.1 billion of SpaceX stock in June.

Via The Motley Fool

Topics ETFs Initial Public Offering

Why Is ARTL Stock Soaring Pre-Market Today? ↗

March 18, 2026

Artelo Biosciences secured a fully-funded study to evaluate the effects of its peripherally selective synthetic cannabinoid, ART27.13, in patients with glaucoma or ocular hypertension.

Via Stocktwits

Topics Artificial Intelligence

OCGN Stock Rallies On Wall Street Optimism For Clinical Pipeline: Retail Awaits New Data ↗

March 17, 2026

Canaccord has a $12 price target on the stock, representing a potential upside of about 415% from the stock’s closing price on Monday.

Via Stocktwits

Why Is This Micro-Cap Biotech Stock Up 150% Today? ↗

March 17, 2026

Despite the LNAI stock soaring on Tuesday, the company’s shares are still down more than 93% from the stock’s 52-week high of $7.7.

Via Stocktwits

Topics Artificial Intelligence Intellectual Property

Why Did NUAI Stock Rise After Hours Today? ↗

March 16, 2026

New Era Energy & Digital said it has appointed Ted Warner as Chief Financial Officer, effective March 16, 2026.

Via Stocktwits

HCWB Stock Soars Pre-Market On Positive Research Results For CAR-T Cell Therapy ↗

March 16, 2026

HCW Biologics said its proprietary multi-cytokine fusion protein reagent, HCW9206, offers a cost-effective way to generate higher-function CAR-T cells for immunotherapy.

Via Stocktwits

Why Is ULY Stock Up Over 160% After Hours? ↗

March 13, 2026

Privately held digital driver assistance service provider Agero, Inc. said that it would acquire Urgent.ly for $5.50 per share.

Via Stocktwits

Topics Government

Why Is Blue Owl Board Urging Shareholders To Reject Minority Offer From Cox And Saba? ↗

March 13, 2026

The company said that it believes the minority offer from Cox and Saba is an attempt to capture value at the expense of OBDC II shareholders.

Via Stocktwits

VELO Stock Rallies More Than 20% On Significant Debt Reduction — Retail Cheers Insider Confidence ↗

March 11, 2026

Velo3D’s CEO Dr. Arun Jeldi purchased a $5 million promissory note from an existing debt holder and converted the same into common stock at $16.38 per share.

Via Stocktwits

Groupon Stock Fell 11% After Hours – Here’s Why ↗

March 10, 2026

The company said its revenue was $132.7 million in the fourth quarter 2025, below analyst expectations of $136.7 million, as per data from Fiscal.ai.

Via Stocktwits

QURE Stock Edges Up After Hours As Analyst Flags Reduced Regulatory Uncertainty Following Prasad’s FDA Exit ↗

March 10, 2026

Mizuho said that Dr. Vinay Prasad’s exit just days after a highly public dispute with uniQure appeared to signal an administration-level desire to restore greater regulatory flexibility in rare disease...

Via Stocktwits

MGNX Closes Up 45% On Wall Street Optimism For Experimental Cancer Therapies ↗

March 10, 2026

Barclays increased the price target on the stock to $4 from $3 and kept an ‘Overweight’ rating on the shares.

Via Stocktwits

Why Did INKT Stock Surge 70% In Pre-Market Today? ↗

March 10, 2026

MiNK Therapeutics tied up with an oncology consortium to develop a cell therapy targeting pediatric cancers.

Via Stocktwits

This Overlooked Vanguard ETF Could Quietly Outperform the S&P 500 Over the Next 5 Years ↗

March 09, 2026

Investors have ridden tech stocks and the S&P 500 for years. But the time for large-caps might finally be coming to an end.

Via The Motley Fool

Topics Artificial Intelligence ETFs Stocks

TRVI Stock Slips After Company Plans Parallel Trials In Lung Disease — Stifel Dismisses Timeline Concerns ↗

March 09, 2026

The company announced its decision following a meeting with the U.S. Food and Drug Administration.

Via Stocktwits

ANTX Stock Records Biggest Ever Single Day Gain, Surges 500% Over Past Four Sessions – What Triggered This Smashing Rally? ↗

March 09, 2026

AN2 Therapeutics shares more than doubled in value on Monday after the company announced a private placement to raise about $40 million.

Via Stocktwits

BBAI Shares Climb After Having Declined 25% This Year — Retail Says Buy Now To Triple Your Money ↗

March 06, 2026

BigBear.ai Holdings posted a 38% decline in Q4 revenue to $27.3 million earlier this week, compared to Wall Street’s estimates of $33.3 million, according to data from Fiscal.ai.

Via Stocktwits

ONDS Stock Jumps 8% Following $6 Million Deal For Its Drone Systems – Retail Sees Validation In Repeat Orders ↗

March 06, 2026

The company announced multiple orders worth for its counter-drone systems, bringing the total to $26 million in March.

Via Stocktwits

Rumble Stock Is Diving After Hours – What Happened To Q4 Revenue? ↗

March 05, 2026

The decline in Q4 revenue was attributable to a decrease in Audience Monetization revenues and lower Other Initiatives revenues. The revenue was in line with analyst expectations, per Fiscal.ai.

Via Stocktwits

Owlet Stock Is Down 26% After Hours – How Did The Company’s Q4 Results Fare? ↗

March 05, 2026

Owlet said that for the first quarter of 2026, it expects revenue in the range of $20 to $21 million. The forecast was significantly lower than Wall Street expectations of $26.2 million.

Via Stocktwits

EONR Stock Is Rallying On Oil Price Spike – What Does Retail Think? ↗

March 05, 2026

U.S. crude oil prices jumped beyond $80 per barrel mark and reached a 52-week high according to data from CNBC.

Via Stocktwits

Topics Energy

Why Did OSRH Stock Jump 20% Today? ↗

March 05, 2026

The company received an additional 180-day extension from Nasdaq to regain compliance after receiving an initial notice on Sept. 9, 2025.

Via Stocktwits

Why Did IBO Stock Surge 65% In Pre-Market Today? ↗

March 05, 2026

The company announced amendments to agreements related to its planned merger with Dr. Ashley's, including extending the deadline to complete the merger to July 1, 2026.

Via Stocktwits

Topics Intellectual Property

Why Did BTAI Stock Surge 20% In Pre-Market Today? ↗

March 05, 2026

BioXcel announced positive Phase 2 results for evaluating treatment for opioid withdrawal symptoms.

Via Stocktwits

BIO-key Discloses Orders From A ‘Foreign Defense Ministry’ – But Stock Loses Initial Gains ↗

March 05, 2026

The company, however, did not disclose the organization's name but stated that it currently supports more than 50,000 licensed users for the ministry.

Via Stocktwits

ASTS Surges Amid Price Target Hikes, Telus Partnership — Here’s Why UBS Is Bullish On The Stock ↗

March 04, 2026

UBS analyst Christopher Schoell highlighted that AST SpaceMobile’s revenue is expected to multiply as the company’s commercial service launch draws closer.

Via Stocktwits

MBOT Stock Falls As Investors Ponder Impact Of Geopolitical Tensions On Israel-Founded Company ↗

March 03, 2026

Microbot said on Tuesday that it is not experiencing any disruption in either the U.S. or Israel with all personnel continuing to operate as usual.

Via Stocktwits

ATRA Rises On Pushing For Meeting With FDA On Rare Disease Drug Rejection ↗

March 03, 2026

FDA refused approval for tabelecleucel in treating patients two years of age and older with Epstein-Barr virus positive post-transplant lymphoproliferative disease earlier this year.

Via Stocktwits

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

About Us

Vanguard Extended Market ETF (NY:VXF)

Headline News about Vanguard Extended Market ETF